Bone Health Markers and Heart Risks in Kidney Disease
New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients
- Age
- 18 – 95
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 250 (estimated)
- Sponsor
- University Hospital, Montpellier · Other
This trial is looking for patients with chronic kidney disease who are not on dialysis. Participants will help researchers understand how certain markers in the blood relate to heart problems over a 7-year period.
You may be able to join if
- I have signed the consent form.
- I have chronic kidney disease.
- I am not currently on dialysis.
You may not be able to join if
- I am pregnant.
- I am on dialysis.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityTo evaluate the relationships between bone mineral metabolism markers (osteoprotegerin, fibroblast growth factor 23) at inclusion and the occurence of cardiovascular events during a 7 year follow-up.
Loading trial locations…